Flow cytometer measurement of binding assays

Claim 2

A process for the immunochemical determination of the amount of antigen present in a sample comprising the steps of: a. providing a known quantity of spheres with antibody coating; b. providing a quantity of smaller spheres with an antigen coating, said antigen being the same as the antigen present in said sample, said smaller spheres being fluorescently labeled; c. combining said known quantity of spheres with sample and allowing reaction between said antigen in said sample and said antibody on said spheres to occur for a set time period; d. combining an excess of said smaller spheres with the mixture of said spheres and said sample produced in step c and then allowing the reactions of antigen in sample and antigen on said smaller spheres with said antibody on said spheres to reach equilibrium; e. simultaneously measuring the fluorescence and light scatter of the combined mixture of sample, spheres, and smaller spheres as said combined mixture passes through a flow cytometer equipped with a laser causing the fluorescent chemical in the smaller spheres to fluoresce; and f. comparing number and strength of fluorescent events caused by spheres having light scatter measurements within a predetermined range against similar events caused by a spheres reacted with a sample of known antigen concentration.

Claim 3

The process of claim 1 wherein said sample and said excess of smaller spheres are added simultaneously to said spheres, and the antigen in said sample and on said smaller spheres is allowed to react with the antibody on said spheres until equilibrium is reached.

Claim 4

The process of claim 1 wherein the spheres are 10 μm in diameter.

Claim 5

The process of claim 3 wherein the smaller spheres are 0.1 μm in diameter.

Claim 6

The process of claim 1 wherein the spheres are composed of latex.

Claim 7

The process of claim 1 wherein the antigen is horseradish peroxidase and the antibody is high avidity, anti-HRP antibody.

Claim 8

The process of claim 1 wherein the flow cytometer is equipped with a argon-ion laser.

Claim 9

A process for the determination of the amount of antigen molecules present in a sample comprising the steps of: a. providing a known quantity of spheres and an excess of smaller spheres, both coated with an antibody, said smaller spheres being fluorescently labeled; b. combining said known quantity of spheres with sample and allowing reaction between said antigen contained in the molecules of said sample and said antibody on said spheres to occur for a set time period; c. combining an excess of said smaller spheres with the mixture of said spheres and said sample produced in step b, and then allowing the reaction of said antibody on said spheres and said smaller spheres with the antigen contained in the molecules in said sample to reach equilibrium; d. simultaneously measuring the fluorescence and light scatter of the combined mixture of sample, spheres, and smaller spheres as said combined mixture passes through a flow cytometer equipped with a laser causing the fluorescent chemical in the smaller spheres to fluoresce; and e. comparing number and strength of fluorescent events caused by spheres having light scatter measurements with in a predetermined range against similar events caused by spheres with no fluorescent smaller spheres present.

Claim 10

A process for the determination of the amount of antigen molecules present in a sample comprising the steps of: a. providing a known quantity of spheres and an excess of smaller spheres, both coated with an antibody, said smaller spheres being fluorescently labeled; b. combining said known quantity of spheres with sample and allowing reaction between said antigen contained in the molecules of said sample and said antibody on said spheres to occur for a set time period; c. combining an excess of said smaller spheres with the mixture of said spheres and said sample produced in step b, and then allowing the reaction of said antibody on said spheres and said smaller spheres with the antigen contained in the molecules in said sample to reach equilibrium; d. simultaneously measuring the fluorescence and light scatter of the combined mixture of sample, spheres, and smaller spheres as said combined mixture passes through a flow cytometer equipped with a laser causing the fluorescent chemical in the smaller spheres to fluoresce; and e. comparing number and strength of fluorescent events caused by spheres having light scatter measurements with in a predetermined range against similar events caused by spheres with no fluorescent smaller spheres present.

Claim 11

The process of claim 8 wherein said sample and said excess of smaller spheres are added simultaneously to said spheres, and the reactions of said antigen with both the antibody on said smaller spheres and the antibody on said spheres are allowed to reach equilibrium simultaneously.

Claim 12

The process of claim 8 wherein the spheres are 10 μm in diameter.

Claim 13

The process of claim 8 wherein the smaller spheres are 0.1 μm in diameter.

Claim 14

The process of claim 8 wherein the spheres are composed of polystyrene latex.

Claim 15

The process of claim 8 wherein the antigen is horseradish peroxidase and the antibody is high avidity, anti-HRP antibody.

Claim 16

The process of claim 8 wherein the flow cytometer is equipped with an argon-ion laser.

Claim 17

A process for the determination of the amount of a binding reactant present in a sample comprising the steps of: a. providing a known quantity of synthetic particles with a coating of binder, (b). providing a quantity of smaller synthetic particles with a coating of binder reactant, said binder reactant being the same as the binder reactant present in the sample, said smaller particles being fluorescently labeled; c. combining said particles with sample and allowing the binding reaction to occur for a set time period, d. combining an excess of smaller particles with the mixture of said particles and sample produced in step c and then allowng the binding reactions of the binder on the particles with the binding reactant on the smaller particles and the binding reactant in the sample to both reach equilibrium; e. simultaneously measuring the fluorescence and light scatter of the combined mixture of sample, particles, and smaller particles as said combined mixture passes through a flow cytometer equipped with a laser causing the fluorescent chemical in smaller particles to fluoresce; and f. comparing number and strength of fluorescent events caused by particles having a light scatter measurement with a predetermined range against similar events caused by particles reacted with a sample of known binder reactant percentage.

Claim 18

A process for the determination of the amount of a binding reactant present in a sample comprising the steps of: a. providing a known quantity of synthetic particles with a coating of binder, (b). providing a quantity of smaller synthetic particles with a coating of binder reactant, said binder reactant being the same as the binder reactant present in the sample, said smaller particles being fluorescently labeled; c. combining said particles with sample and allowing the binding reaction to occur for a set time period, d. combining an excess of smaller particles with the mixture of said particles and sample produced in step c and then allowng the binding reactions of the binder on the particles with the binding reactant on the smaller particles and the binding reactant in the sample to both reach equilibrium; e. simultaneously measuring the fluorescence and light scatter of the combined mixture of sample, particles, and smaller particles as said combined mixture passes through a flow cytometer equipped with a laser causing the fluorescent chemical in smaller particles to fluoresce; and f. comparing number and strength of fluorescent events caused by particles having a light scatter measurement with a predetermined range against similar events caused by particles reacted with a sample of known binder reactant percentage.

Claim 19

The process of claim 15 wherein the binding reactant is a ligand and the binder is a receptor for said ligand.

Claim 20

The process of claim 15 wherein the binder is an enzyme and the binding reactant is the substrate for said enzyme.

Claim 21

The process of claim 15 wherein the binding reactant is a hapten and the binder is an antibody for said hapten.